JOURNAL OF UROLOGY AND ANDROLOGY RESEARCH

Aims and Scope

The Journal of Urology and Andrology Research (JUAR) aims to serve as a premier, peer-reviewed, open-access platform dedicated to advancing scientific and clinical knowledge in the full spectrum of urological and andrological disorders. Published by the Australasian Publishing Group, the journal seeks to bridge the gap between cutting-edge basic science, translational research, and evidence-based clinical practice.

Primary aim and objectives include:

  1. To disseminate high-impact research covering diagnostic, medical, surgical, and rehabilitative aspects of genitourinary tract diseases and male reproductive health.
  2. To foster interdisciplinary collaboration among urologists, andrologists, reproductive endocrinologists, oncologists, radiologists, pathologists, and basic scientists.
  3. To highlight regional health priorities in the Australasian and Asia-Pacific regions (e.g., prostate cancer epidemiology, male infertility trends, access to urological care in remote areas) while maintaining global relevance.
  4. To promote innovations in minimally invasive surgery, robotic urology, laser therapies, regenerative medicine, biomarkers, and precision oncology.
  5. To elevate andrology as a distinct subspecialty by emphasizing male sexual dysfunction, hypogonadism, fertility preservation, and environmental impacts on male reproduction.
  6. To support early-career researchers through methodological articles, systematic reviews, and clinical trial updates.

Scope of the journal

The Journal of Urology and Andrology Research welcomes original research, comprehensive reviews, case series, technical notes, guidelines, and editorials covering all aspects of urology and andrology. The scope is structured around five core pillars:

Urologic Oncology

  • Prostate, bladder, kidney, testicular, penile, and upper tract urothelial cancers
  • Biomarkers, genomics, immunotherapy, targeted therapy
  • Active surveillance, radical surgery, focal therapy
  • Palliative and survivorship care

Voiding Dysfunction & Female Urology

  • Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)
  • Overactive bladder (OAB), neurogenic bladder, interstitial cystitis/bladder pain syndrome
  • Urinary incontinence (stress, urge, mixed) and pelvic organ prolapse
  • Urodynamics and neuromodulation

Endourology, Robotics & Minimally Invasive Surgery

  • Percutaneous nephrolithotomy (PCNL), ureteroscopy (RIRS/fURS), ESWL
  • Laparoscopic and robot-assisted surgery (e.g., RALP, partial nephrectomy, cystectomy)
  • Laser lithotripsy (Ho:YAG, thulium) and enucleation techniques
  • Single-port surgery, AI-assisted surgical planning

Andrology & Male Reproductive Health

  • Male infertility (azoospermia, oligospermia, varicocele, genetic causes)
  • Erectile dysfunction (ED), Peyronie’s disease, priapism
  • Hypogonadism, testosterone replacement therapy (TRT), male contraception
  • Vasectomy, vasectomy reversal, sperm retrieval (TESA, TESE, micro-TESE)
  • Environmental, lifestyle, and occupational impacts on spermatogenesis

Reconstructive Urology, Trauma & Infections

  • Urethral stricture, hypospadias, phalloplasty, genital reconstruction
  • Genitourinary trauma and fistulae management
  • Chronic prostatitis, epididymitis, sexually transmitted infections (STIs)
  • Fournier’s gangrene, penile prostheses, artificial urinary sphincter

Pediatric & Transplant Urology

  • Congenital anomalies (hypospadias, UPJ obstruction, posterior urethral valves)
  • Pediatric stone disease, voiding dysfunction, enuresis
  • Renal transplantation – surgical techniques, urological complications, immunosuppression-related urologic issues

Basic & Translational Research

  • Molecular mechanisms of urologic diseases (e.g., prostate hyperplasia, stone formation).
  • Stem cell applications, tissue engineering, and biomarkers.

Pharmacology & Drug Development

  • Medical management of BPH, overactive bladder, and erectile dysfunction.
  • Clinical trials on new urological/andrological drugs.

Ethics, Education & Public Health in Urology and Andrology

  • Informed consent, conflict of interest management, and equitable access to reproductive and surgical care
  • Simulation-based training, e-learning, and tele-mentorship for low-resource settings
  • Public awareness campaigns for prostate cancer, testicular self-examination, and ED as a cardiovascular marker
  • Environmental and preventive health (male infertility as a sentinel marker, kidney stone prevention)
  • Reducing global disparities in fertility preservation, vasectomy, hypogonadism treatment, and urologic oncology